The Japan Osaka Pharmaceutical Laboratory and Biopharmaceutical R&D Technology Exhibition (BioPharma Expo) covers research and development technologies, manufacturing technologies, and contract services. It attracts visitors, exhibitors, and professionals in the biopharmaceutical technology field from all over the world.

Japan has become the second largest country in terms of R&D investment in the biopharmaceutical industry worldwide, ranking third in the global pharmaceutical and biotechnology market behind the United States and China. The investment scale in the research and development sector ranks second globally. Moreover, the global biopharmaceutical industry is developing rapidly.

The Japan Osaka Pharmaceutical Laboratory and Biopharmaceutical R&D Technology Exhibition (BioPharma Expo) gathers 450 global pharmaceutical companies to explore new trends in antibody drugs, cell therapies, and AI-driven R&D. The PMDA policy forum + Sino-Japanese summit helps seize the first-mover advantage in the Asian biopharmaceutical market.

In recent years, with the growth of Japan's aging population, the demand for related industries in the country has been increasing year by year. At the same time, the Japanese government is actively promoting pharmaceutical market innovation policies, which require strong support from international markets, introducing new technologies and resources, especially in new drug testing and development, stem cell regenerative medicine, and the standardization and practical application of cell therapies, as well as safety testing technology for new drugs.

Exhibitions by Zojun have organized several high-quality enterprises to participate! The Japan Osaka Pharmaceutical Laboratory and Biopharmaceutical R&D Technology Exhibition (BioPharma Expo) brings unlimited business opportunities to merchants from various countries. (The content of this article is owned by Zojun and shall not be forwarded without permission.)